TY - JOUR
T1 - Hypertension-Related Cardiovascular Mortality in Asian American Subgroups
AU - Shah, Nilay S.
AU - Shimbo, Daichi
AU - Muntner, Paul
AU - Huffman, Mark D.
AU - Kandula, Namratha R.
AU - Mefford, Matthew T.
AU - Lloyd-Jones, Donald M.
AU - Khan, Sadiya S.
N1 - Funding Information:
This study was supported in part by National Heart, Lung, and Blood Institute Grants K23HL157766 to NSS and R01HL161514 and R01HL159250 to SSK. MDH has pending patents for heart failure polypills. George Health Enterprises Pty Ltd. And its subsidiary, George Medicines Pty Ltd. have received investment funds to develop fixed-dose combination products, including combinations of blood pressure-lowering drugs. George Health Enterprises Pty Ltd. is the social enterprise arm of The George Institute for Global Health. No other financial disclosures were reported. Nilay S. Shah: Conceptualization, Formal analysis, Funding acquisition, Methodology, Supervision, Visualization, Writing - original draft. Daichi Shimbo: Conceptualization; Writing – review & editing. Paul Muntner: Conceptualization; Writing – review & editing. Mark D. Huffman: Conceptualization, Writing – review & editing. Namratha R. Kandula: Conceptualization, Writing – review & editing. Matthew T. Mefford: Writing – review & editing. Donald M. Lloyd-Jones: Conceptualization, Writing – review & editing. Sadiya S. Khan: Conceptualization, Funding acquisition, Methodology, Supervision, Writing – review & editing.
Funding Information:
This study was supported in part by National Heart, Lung, and Blood Institute Grants K23HL157766 to NSS and R01HL161514 and R01HL159250 to SSK.
Publisher Copyright:
© 2023 American Journal of Preventive Medicine
PY - 2023
Y1 - 2023
N2 - Introduction: Asian American subgroups experience heterogeneity in cardiovascular disease, but differences in hypertension-related cardiovascular disease mortality between Asian American subgroups is not known. Methods: Among 1,194,648 deaths in the United States in 2018-2021 with cardiovascular disease as an underlying cause and hypertension-related diseases as contributing cause, sex-specific age-standardized mortality rates, proportional mortality, and proportional mortality ratios for non-Hispanic Asian and Asian subgroups, Hispanic, and non-Hispanic Black individuals were compared with non-Hispanic White individuals. The analysis was conducted in August 2022. Results: There were 37,746; 95,404; 193,899; and 867,599 hypertension-related cardiovascular disease deaths in non-Hispanic Asian; Hispanic; non-Hispanic Black; and non-Hispanic White groups, respectively. Among non-Hispanic Asian females, mortality rates ranged from 41.6 (95% CI 40.0-43.3) per 100,000 population in Japanese to 52.6 (51.0-54.2) per 100,000 in Filipina individuals. Among non-Hispanic Asian males, mortality rates ranged from 45.8 (43.3-48.2) per 100,000 in Korean to 81.0 (78.5-83.5) per 100,000 in Filipino individuals. Proportional mortality was higher for all Asian American subgroups compared to non-Hispanic White individuals. Proportional mortality ratios ranged from 1.11 (in Korean males, proportional mortality was 10.2% [95% CI 9.7-10.8] of all deaths) to 1.38 (in Filipino males, proportional mortality was 12.7% [12.4-13.1] of all deaths; in Chinese females, proportional mortality was 11.9% [11.6-12.3]; and in Filipina females, proportional mortality was 11.9% [12.3-13.0]). Conclusions: There was up to two-fold variation in hypertension-related cardiovascular disease mortality among Asian American subgroups. All subgroups experienced higher proportional mortality for hypertension-related cardiovascular disease compared with non-Hispanic White individuals.
AB - Introduction: Asian American subgroups experience heterogeneity in cardiovascular disease, but differences in hypertension-related cardiovascular disease mortality between Asian American subgroups is not known. Methods: Among 1,194,648 deaths in the United States in 2018-2021 with cardiovascular disease as an underlying cause and hypertension-related diseases as contributing cause, sex-specific age-standardized mortality rates, proportional mortality, and proportional mortality ratios for non-Hispanic Asian and Asian subgroups, Hispanic, and non-Hispanic Black individuals were compared with non-Hispanic White individuals. The analysis was conducted in August 2022. Results: There were 37,746; 95,404; 193,899; and 867,599 hypertension-related cardiovascular disease deaths in non-Hispanic Asian; Hispanic; non-Hispanic Black; and non-Hispanic White groups, respectively. Among non-Hispanic Asian females, mortality rates ranged from 41.6 (95% CI 40.0-43.3) per 100,000 population in Japanese to 52.6 (51.0-54.2) per 100,000 in Filipina individuals. Among non-Hispanic Asian males, mortality rates ranged from 45.8 (43.3-48.2) per 100,000 in Korean to 81.0 (78.5-83.5) per 100,000 in Filipino individuals. Proportional mortality was higher for all Asian American subgroups compared to non-Hispanic White individuals. Proportional mortality ratios ranged from 1.11 (in Korean males, proportional mortality was 10.2% [95% CI 9.7-10.8] of all deaths) to 1.38 (in Filipino males, proportional mortality was 12.7% [12.4-13.1] of all deaths; in Chinese females, proportional mortality was 11.9% [11.6-12.3]; and in Filipina females, proportional mortality was 11.9% [12.3-13.0]). Conclusions: There was up to two-fold variation in hypertension-related cardiovascular disease mortality among Asian American subgroups. All subgroups experienced higher proportional mortality for hypertension-related cardiovascular disease compared with non-Hispanic White individuals.
UR - http://www.scopus.com/inward/record.url?scp=85147567013&partnerID=8YFLogxK
U2 - 10.1016/j.amepre.2023.01.003
DO - 10.1016/j.amepre.2023.01.003
M3 - Article
C2 - 36759227
AN - SCOPUS:85147567013
SN - 0749-3797
JO - American Journal of Preventive Medicine
JF - American Journal of Preventive Medicine
ER -